MedTrace Logo

A Study to Compare the Pharmacokinetics of YM150 Formulation-A and Formulation-B

NCT01125657 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2010-05-25

No results posted yet for this study

Summary

This study is to compare its pharmacokinetics profile of two YM150 formulations by 2x2 crossover method.

Conditions

  • Healthy Volunteer
  • Pharmacokinetics of YM150

Interventions

DRUG

YM150

oral

Sponsors & Collaborators

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Use Central Contact · Astellas Pharma Inc

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
44 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Japan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01125657 on ClinicalTrials.gov